93 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 93 of 93 clinical reviews.
A guide to AndroGel safety for adolescents aged 12, 17, covering bone-age acceleration, growth-plate closure, mental-health monitoring, transfer risk, and FDA labeling for male hypogonadism.
Evidence-based guide to AndroGel (testosterone gel) dosing in adolescents aged 12 to 17, covering off-label use, starting doses, titration, monitoring, and safety considerations for male hypogonadism.
Evidence-based monitoring protocols for AndroGel (testosterone gel) use in male adolescents aged 12, 17, covering serum testosterone targets, bone age, growth velocity, hematocrit, and mental health checks.
Evidence-based AndroGel dosing for men aged 30-49 with hypogonadism: starting doses, titration schedules, application sites, monitoring labs, and when to adjust. prepared by the HealthRX.com Editorial Team.
A physician-level review of every clinically significant drug-drug interaction for AndroGel (testosterone gel 1% and 1.62%), with mechanisms, dosing implications, and monitoring protocols backed by FDA labeling and primary literature.
AndroGel costs about $510/month cash in Alabama. Learn how to cut that price with manufacturer cards, compounded alternatives, insurance options, and telehealth access.
AndroGel costs $510/month cash in California in 2026. Learn about Medi-Cal coverage, AbbVie savings cards, compounded testosterone gel alternatives, and telehealth options for CA residents.
Current AndroGel prices in Delaware for 2026, including cash-pay costs, Medicaid coverage with prior authorization, compounded alternatives, AbbVie savings cards, and telehealth access.
AndroGel costs about $510/month cash in Florida. Learn which insurance plans cover it, whether Florida Medicaid pays, how compounded testosterone gel runs $120/month, and how to use the AbbVie savings card.
A breakdown of AndroGel prices in Georgia for 2026, including cash-pay rates, Georgia Medicaid coverage rules, AbbVie savings cards, and legal compounded testosterone gel options via 503A pharmacies.
AndroGel costs around $510/month cash pay at Hawaii retail pharmacies in 2026. Hawaii Medicaid does not cover it. Licensed 503A compounding pharmacies offer testosterone gel from about $120/month. This guide covers every cost-reduction path available to Hawaii residents.
Find out exactly what AndroGel costs in Idaho in 2026, whether Idaho Medicaid covers it, how compounded testosterone gel compares, and the fastest ways to lower your out-of-pocket expense.
What does AndroGel cost in Illinois in 2026? This guide covers retail prices, Illinois Medicaid coverage, AbbVie savings cards, compounded testosterone gel, and telehealth prescribing, with data.
A complete guide to AndroGel pricing, Kentucky Medicaid coverage, compounded testosterone gel legality, insurance options, and savings programs for Kentucky residents in 2026.
AndroGel costs about $510/month cash in Louisiana. Learn about Medicaid coverage, insurance options, compounded testosterone gel alternatives, and discount programs available to LA residents.
Find out exactly what AndroGel costs in Maine in 2026, whether Maine Medicaid or private insurance covers it, how compounded testosterone gel compares, and how to pay less.
What AndroGel actually costs in Massachusetts in 2026, from AbbVie list price to Medicaid PA requirements, compounded alternatives, and telehealth pathways. prepared by the HealthRX.com Editorial Team.
A complete 2026 guide to AndroGel pricing in Michigan, covering cash-pay rates, Medicaid prior authorization, AbbVie savings cards, compounded testosterone gel via 503A pharmacies, and telehealth prescribing options.
Find out exactly what AndroGel costs in Minnesota in 2026, whether Minnesota Medicaid covers it, how the AbbVie savings card works, and when compounded testosterone gel is a legal lower-cost option.
Find out exactly what AndroGel costs in Nebraska in 2026, whether Nebraska Medicaid covers it, how AbbVie's savings card works, and whether compounded testosterone gel is a legal lower-cost option.
Find out exactly what AndroGel costs in Oregon in 2026, whether Oregon Medicaid covers it, how compounded testosterone gel compares, and how to pay less with or without insurance.
Find out exactly what AndroGel costs in Tennessee in 2026, whether TN Medicaid covers it, how compounded testosterone gel compares, and the fastest way to lower your monthly bill.
The full breakdown of AndroGel cost in Texas for 2026, including cash price, insurance coverage, Texas Medicaid rules, compounded testosterone gel legality, and how to cut your monthly bill.
A complete 2026 guide to AndroGel pricing in Virginia, covering retail cash pay, AbbVie savings cards, Virginia Medicaid prior authorization, compounded testosterone gel legality, and telehealth prescribing options.
Compare AndroGel pricing against generic testosterone gel, injections, patches, pellets, and oral TRT. Includes per-month costs, clinical efficacy data, and insurance considerations.
Clinical guide to testosterone gel (AndroGel) dosing in men aged 50-64, covering initiation, titration, cardiovascular monitoring, and polypharmacy considerations.
Evidence-based AndroGel (testosterone gel) dosing guide for men aged 18, 29 with hypogonadism. Covers starting doses, titration, lab monitoring, fertility considerations, and application technique.
A guide to AndroGel (testosterone gel 1% and 1.62%) dosing when liver function is compromised, covering pharmacokinetics, FDA labeling, safety monitoring, and clinical decision-making.
A guide to AndroGel (testosterone gel) dosing in chronic kidney disease and renal impairment, covering pharmacokinetics, safety data, monitoring protocols, and how testosterone gel works.
A guide to food, supplement, and nutrient interactions with AndroGel (testosterone gel), including absorption risks, liver enzyme effects, and timing strategies.
Complete clinical guide to AndroGel (testosterone gel 1% and 1.62%) for male hypogonadism. Covers FDA approval, TRT Trials evidence, dosing protocols, side effects, insurance, and answers to common patient questions.
Clinical guide to using AndroGel (testosterone gel 1%) for secondary hypogonadism, including FDA status, dosing protocols, T-Trials evidence, fertility considerations, and insurance coverage.
A deep dive into AndroGel's mechanism of action, current limitations, and the testosterone gel pipeline, including novel transdermal systems, nasal gels, subcutaneous pellets, and oral alternatives backed by PubMed and FDA data.
Evidence-based monitoring protocol for AndroGel (testosterone gel) in men aged 65 and older, covering lab intervals, cardiovascular screening, PSA tracking, hematocrit thresholds, and when to stop therapy.
A guide to AndroGel (testosterone gel 1% and 1.62%) safety in men aged 65 and older, covering cardiovascular risk, falls, polypharmacy, renal considerations, and when deprescribing makes sense.
Evidence-based AndroGel dosing guidance for men aged 65 and older, covering starting doses, titration, monitoring, drug interactions, and safety considerations specific to geriatric patients.
A clinical history of AndroGel (testosterone gel), covering its FDA approval, formulation evolution, landmark trials like the T-Trials, patent battles, and role in modern hypogonadism treatment.
Evidence-based guide to testosterone gel (AndroGel) use in special populations including HIV-associated hypogonadism, organ transplant recipients, opioid-induced and glucocorticoid-induced testosterone deficiency.
AndroGel is a topical testosterone gel, not an injectable. Learn the correct application technique, dosing, absorption science, and how it compares to injectable TRT options.
A clinical deep-dive into AndroGel's manufacturing timeline, FDA supply disruptions, testosterone gel production challenges, and current availability status.
A physician-level explanation of how AndroGel (testosterone gel 1%) works, from transdermal absorption through 5α-reductase conversion, androgen receptor activation, and HPG axis feedback.
Evidence-based guide to handling missed doses of AndroGel (testosterone gel 1% and 1.62%). Covers the pharmacokinetic basis for the FDA-labeled missed-dose instruction, what is and is not established about recovery timing, and when a missed dose becomes a reason to call your prescriber.
A complete guide to monitoring testosterone levels, hematocrit, PSA, and metabolic markers while using AndroGel (testosterone gel) in men aged 30 to 49.
A guide to monitoring AndroGel (testosterone gel) in men aged 50, 64, covering serum testosterone targets, hematocrit, PSA, cardiovascular risk, and polypharmacy considerations with primary-source citations throughout.
A complete clinical guide to AndroGel (testosterone gel) monitoring for men aged 18, 29, covering lab timing, fertility preservation, hematocrit thresholds, PSA, cardiovascular markers, and lifestyle integration.
A physician-level guide to the lab tests, physical exams, and follow-up intervals required while using AndroGel (testosterone gel), with timelines drawn from AES, Endocrine Society, and FDA guidance.
Evidence-based guide to testosterone gel (AndroGel) overdose management, including signs of accidental excess dosing, secondary transfer risks, FDA safety data, and step-by-step clinical response protocols.
A breakdown of AndroGel's patent history, generic testosterone gel options, mechanism of action, and what the T-Trials show about efficacy. Includes dosing, bioavailability data, and FDA approval dates.
A clinical guide to AndroGel (testosterone gel) dosing in children under 12, covering FDA labeling, weight-based considerations, safety monitoring, and evidence from pediatric endocrinology guidelines.
A clinician-focused guide to monitoring children under 12 exposed to AndroGel (testosterone gel): bone age, growth velocity, hormone panels, virilization signs, and safety protocols based on FDA labeling and pediatric endocrinology guidelines.
A guide to AndroGel (testosterone gel) safety in children under 12, covering accidental exposure risks, FDA black-box warnings, secondary virilization, and safe handling protocols.
Genetic variants in AR, SRD5A2, UGT2B17, and CYP19A1 alter how men absorb, metabolize, and respond to AndroGel (testosterone gel). Here is what the pharmacogenomic evidence means for TRT dosing.
AndroGel half life: free testosterone clears in 10 to 100 minutes, but skin-reservoir release means levels fall to baseline 48 to 72 hours after stopping.
AndroGel (testosterone gel) carries an FDA Category X rating in pregnancy and poses secondary transfer risks during lactation. This guide covers teratogenicity data, transfer mechanisms, contraceptive requirements, and safe handling protocols.
A clinical review of real-world evidence for AndroGel (testosterone gel), including registry data from RHYME, T-Trials outcomes, TRAVERSE cardiovascular findings, and claims-database analyses of adherence and safety.
A clinical review of AndroGel (testosterone gel) regulatory approvals, prescribing restrictions, and market availability across the United States, European Union, Canada, and United Kingdom.
A guide to AndroGel (testosterone gel 1% and 1.62%) safety for men ages 50 to 64, covering cardiovascular risk, prostate monitoring, polypharmacy, dosing, and what the T-Trials data actually show.
A guide to AndroGel (testosterone gel) safety for men aged 18, 29, covering fertility, bone health, cardiovascular risk, dosing, and monitoring protocols based on current evidence.
A clinical review of every major FDA safety action on AndroGel (testosterone gel), from the 2014 cardiovascular review through the 2023 TRAVERSE trial, with primary-source citations.
How to store AndroGel testosterone gel correctly, what temperature and expiration limits actually mean for potency, and when a storage problem should be ruled out before changing a dose.
Showing the first 60 matches. Use search or filters to narrow the library.